Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial Fibrillation (DYNAMIC AF Registry)
Key facts
- Who runs it
- Heart Rhythm Clinical and Research Solutions, LLC
- Where
- Annapolis, Birmingham, Boston, and Philadelphia, United StatesSee the 4 sites
- Trial code
- Status
- Terminated
- People taking part
- 392 people enrolled
- Started
- 10 Jan 2022
- Ended
- 31 Dec 2023
- Type of study
- Observational, 3 groups
- Treatments tested
- Catheter Ablation
- Record updated
- 12 January 2024
- Why it stopped
- Decision made to close enrollment in October and close the registry by December 2023
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Patients with symptomatic, refractory or intolerant to at least one Class I or III AAD, paroxysmal atrial fibrillation (AF episode terminating spontaneously within 7 days) or symptomatic, refractory or intolerant to at least one Class I or III AAD, persistent AF (continuous AF sustained beyond 7-days and less than 1-year) who, in the opinion of the investigator, are candidates for ablation for AF. Refusal to take AADs for any reason is considered intolerant for the purposes of this protocol
- Plans to undergo an RF catheter ablation procedure using an ablation catheter manufactured by Abbott
- De Novo ablation unless it is a repeat procedure for a subject whose index procedure is also included in the registry
- 18 years of age or older
- Able and willing to participate in baseline and follow up evaluations for the full length of the registry
Who cannot take part
- Participating in another clinical trial or has participated in a clinical trial within 30 days prior to screening that may interfere with this registry
- Previous left atrial surgery for atrial fibrillation
- In the opinion of the investigator, any known contraindication to an ablation procedure or to any device or drug required for use during an ablation procedure as assessed by the investigator
- Pregnant women
- Individual who cannot read or write, or those who cannot legally consent for themselves
- Long-standing persistent AF (continuous AF sustained >=1 year)
- Having a repeat ablation, unless the subject's index ablation procedure is also included in the registry
Where in United States
- Luminis Health Anne Arundel Medical CenterAnnapolis, United States
- Grandview Medical CenterBirmingham, United States
- Brigham and Women's HospitalBoston, United States
- Penn Presbyterian HospitalPhiladelphia, United States
About the trial
What the trial wants to find out
DYNAMIC AF is an observational, prospective, multi-center, non-randomized registry designed to obtain real world clinical experience of radiofrequency (RF) ablation for the treatment of paroxysmal (PAF) and persistent (PsAF) atrial fibrillation ablation. Patient assessments will occur at pre- procedure, procedure, 12 weeks, 6 months and 1 year post ablation.
The 3 groups in the trial
- Acute SOC Sites with Patients with paroxysmal or persistent atrial fibrillation
Patients with symptomatic, refractory or intolerant to at least one Class I or III AAD, paroxysmal atrial fibrillation (AF episode terminating spontaneously within 7 days) or symptomatic, refractory or intolerant to at least one Class I or III AAD, persistent AF (continuous AF sustained beyond 7-days and less than 1-year) who, in the opinion of the investigator, are candidates for ablation for AF.
Treatment: Catheter Ablation
- Symptomatic Monitoring SOC Sites with Patients with paroxysmal or persistent atrial fibrillation
Patients with symptomatic, refractory or intolerant to at least one Class I or III AAD, paroxysmal atrial fibrillation (AF episode terminating spontaneously within 7 days) or symptomatic, refractory or intolerant to at least one Class I or III AAD, persistent AF (continuous AF sustained beyond 7-days and less than 1-year) who, in the opinion of the investigator, are candidates for ablation for AF.
Treatment: Catheter Ablation
- Full Monitoring SOC Sites with Patients with paroxysmal or persistent atrial fibrillation
Patients with symptomatic, refractory or intolerant to at least one Class I or III AAD, paroxysmal atrial fibrillation (AF episode terminating spontaneously within 7 days) or symptomatic, refractory or intolerant to at least one Class I or III AAD, persistent AF (continuous AF sustained beyond 7-days and less than 1-year) who, in the opinion of the investigator, are candidates for ablation for AF.
Treatment: Catheter Ablation
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multi-Center, Real-World Evidence Registry to Assess Outcomes for the Long-Term Impact of Catheter Ablation for Atrial Fibrillation: DYNAMIC AF Registry
- Record updated
- 12 January 2024